Skip to main content
Top
Published in: Annals of Surgical Oncology 3/2017

01-12-2017 | Gastrointestinal Oncology

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Trial Results of a Phase 2, Randomized, Clinical Trial

Authors: Peng Wang, MD, Zhi-xiang Zhou, MD

Published in: Annals of Surgical Oncology | Special Issue 3/2017

Login to get access

Excerpt

With great interest, we have read the phase 2, randomized, clinical trial published in the Annals of Surgical Oncology (2011;18(6):1575–81) by Yang et al. Great efforts have been made to prove that synchronous gastric peritoneal carcinomatosis (PC), cytoreductive surgery (CRS) + hyperthermic intraperitoneal chemotherapy (HIPEC) with mitomycin C 30 mg, and cisplatin 120 mg may improve survival with acceptable morbidity. …
Metadata
Title
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Trial Results of a Phase 2, Randomized, Clinical Trial
Authors
Peng Wang, MD
Zhi-xiang Zhou, MD
Publication date
01-12-2017
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue Special Issue 3/2017
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-017-6148-0

Other articles of this Special Issue 3/2017

Annals of Surgical Oncology 3/2017 Go to the issue